Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Relvar“
Suchtreffer
Begriffe & Kennungen
Relvar Ellipta · 4.8 · **Fractures
Eintrag öffnenRelvar Ellipta · 4.8 · **Fractures
Eintrag öffnenRelvar Ellipta · 4.8 · *, ** See below ‘Description of selected adverse reactions’
Eintrag öffnenRelvar Ellipta · 4.8 · *, ** See below ‘Description of selected adverse reactions’
Eintrag öffnenRelvar Ellipta · 4.8 · *Pneumonia (see section 4.4)
Eintrag öffnenRelvar Ellipta · 4.8 · *Pneumonia (see section 4.4)
Eintrag öffnenRelvar Ellipta · 4.8 · 10 System organ class Adverse reaction(s) Frequency General disorders and Pyrexia Common administration site c
Eintrag öffnenRelvar Ellipta · 4.8 · 32 System organ class Adverse reaction(s) Frequency Infections and infestations Pneumonia* Common Upper respir
Eintrag öffnenRelvar Ellipta · 4.8 · 33 events (6%, 5%, 4%, 5%); serious adverse events (3%, 4%, 3%, 3%); adjudicated on treatment deaths due to pn
Eintrag öffnenRelvar Ellipta · 4.8 · Adverse reactions are listed by system organ class and frequency. The following convention has been used for t
Eintrag öffnenRelvar Ellipta · 4.8 · Adverse reactions are listed by system organ class and frequency. The following convention has been used for t
Eintrag öffnenRelvar Ellipta · 4.8 · Data from large asthma and COPD clinical trials were used to determine the frequency of adverse reactions asso
Eintrag öffnenRelvar Ellipta · 4.8 · Data from large asthma and COPD clinical trials were used to determine the frequency of adverse reactions asso
Eintrag öffnenRelvar Ellipta · 4.8 · Description of selected adverse reactions
Eintrag öffnenRelvar Ellipta · 4.8 · Description of selected adverse reactions
Eintrag öffnenRelvar Ellipta · 4.8 · For the SUMMIT study, the incidence of all events of fracture with FF/VI, FF, VI and placebo were 2% in each a
Eintrag öffnenRelvar Ellipta · 4.8 · For the SUMMIT study, the incidence of all events of fracture with FF/VI, FF, VI and placebo were 2% in each a
Eintrag öffnenRelvar Ellipta · 4.8 · In a placebo-controlled study (SUMMIT) in subjects with moderate COPD (mean percent post- bronchodilator scree
Eintrag öffnenRelvar Ellipta · 4.8 · In a placebo-controlled study (SUMMIT) in subjects with moderate COPD (mean percent post- bronchodilator scree
Eintrag öffnenRelvar Ellipta · 4.8 · In an integrated analysis of 11 studies in asthma (7,034 patients), the incidence of pneumonia per 1000 patien
Eintrag öffnen